Optimized mouse model for the imaging of tumor metastasis upon experimental therapy

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Lavilla Alonso, Sergio ^a,b   Abo Ramadan, Usama ^b   Halavaara, Juha ^b,c   Escutenaire, Sophie ^a,b   Tatlisumak, Turgut ^b   Saksela, Kalle ^a   Kanerva, Anna ^a,b   Hemminki, Akseli ^a,b   Pesonen, Sari ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c JORVI HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLYTIC ADENOVIRUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; COLORECTAL CANCER; CONTROLLED STUDY; EXPERIMENTAL MODEL; EXPERIMENTAL THERAPY; FEMALE; HUMAN; HUMAN CELL; IMAGE QUALITY; IMPLANTATION; LIVER METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLYTIC VIROTHERAPY; PRIMARY TUMOR; REPRODUCIBILITY; SCID MOUSE; SPLEEN; TUMOR GROWTH; ANIMAL; DISEASE MODEL; EXPERIMENTAL NEOPLASM; METASTASIS; MOUSE MUTANT; PATHOLOGY; TUMOR CELL LINE;

ADENOVIRIDAE; ANIMALIA; MUS;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, SCID; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL;

EID: 80455131140     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026810     Document Type: Article

References (23)

1. Ito K, Govindarajan A, Ito H, Fong Y, (2010) Surgical treatment of hepatic colorectal metastasis: Evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century. Cancer J 16: 103-110.
2. Meads MB, Gatenby RA, Dalton WS, (2009) Environment-mediated drug resistance: A major contributor to minimal residual disease. Nat Rev Cancer 9: 665-674.
3. Zechmann CM, Woenne EC, Brix G, Radzwill N, Ilg M, et al. (2007) Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors. Neoplasia 9: 57-67.
4. Klein CA, (2009) Parallel progression of primary tumours and metastases. Nat Rev Cancer 9: 302-312.
5. Peeters CF, de Waal RM, Wobbes T, Ruers TJ, (2008) Metastatic dormancy imposed by the primary tumor: Does it exist in humans? Ann Surg Oncol 15: 3308-3315.
6. Nguyen DX, Bos PD, Massague J, (2009) Metastasis: From dissemination to organ-specific colonization. Nat Rev Cancer 9: 274-284.
7. Khanna C, Hunter K, (2005) Modeling metastasis in vivo. Carcinogenesis 26: 513-523.
8. Yamamoto N, Yang M, Jiang P, Xu M, Tsuchiya H, et al. (2003) Determination of clonality of metastasis by cell-specific color-coded fluorescent-protein imaging. Cancer Res 63: 7785-7790.
9. Hansen K, Khanna C, (2004) Spontaneous and genetically engineered animal models; use in preclinical cancer drug development. Eur J Cancer 40: 858-880.
10. Koike N, Cho A, Nasu K, Seto K, Nagaya S, et al. (2009) Role of diffusion-weighted magnetic resonance imaging in the differential diagnosis of focal hepatic lesions. World J Gastroenterol 15: 5805-5812.
11. Seymour R, Sundberg JP, Hogenesch H, (2006) Abnormal lymphoid organ development in immunodeficient mutant mice. Vet Pathol 43: 401-423.
12. Liu XY, Gu JF, (2006) Targeting gene-virotherapy of cancer. Cell Res 16: 740.
13. Bouvet M, Tsuji K, Yang M, Jiang P, Moossa AR, et al. (2006) In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases. Cancer Res 66: 11293-11297.
14. Fukumura D, Jain RK, (2007) Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization. Microvasc Res 74: 72-84.
15. Nakagawa H, Liyanarachchi S, Davuluri RV, Auer H, Martin EW, et al. (2004) Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 23: 7366-7377.
16. Bockhorn M, Jain RK, Munn LL, (2007) Active versus passive mechanisms in metastasis: Do cancer cells crawl into vessels, or are they pushed? Lancet Oncol 8: 444-448.
17. Joyce JA, Pollard JW, (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252.
18. Chiappa A, Makuuchi M, Lygidakis NJ, Zbar AP, Chong G, et al. (2009) The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy. Crit Rev Oncol Hematol 72: 65-75.
19. Satoh Y, Esche C, Gambotto A, Shurin GV, Yurkovetsky ZR, et al. (2002) Local administration of il-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice. J Exp Ther Oncol 2: 337-349.
20. Thalheimer A, Otto C, Bueter M, Illert B, Gattenlohner S, et al. (2009) Tumor cell dissemination in a human colon cancer animal model: Orthotopic implantation or intraportal injection? Eur Surg Res 42: 195-200.
21. Cespedes MV, Espina C, Garcia-Cabezas MA, Trias M, Boluda A, et al. (2007) Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am J Pathol 170: 1077-1085.
22. Bauerschmitz GJ, Lam JT, Kanerva A, Suzuki K, Nettelbeck DM, et al. (2002) Treatment of ovarian cancer with a tropism modified oncolytic adenovirus. Cancer Res 62: 1266-1270.
23. Yu HK, Kim JS, Lee HJ, Ahn JH, Lee SK, et al. (2004) Suppression of colorectal cancer liver metastasis and extension of survival by expression of apolipoprotein(a) kringles. Cancer Res 64: 7092-7098.